Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Grows By 15.9%

AstraZeneca PLC (OTCMKTS:AZNCF) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 67,800 shares, an increase of 15.9% from the March 15th total of 58,500 shares. Based on an average daily volume of 3,300 shares, the days-to-cover ratio is presently 20.5 days.

AstraZeneca Stock Performance

OTCMKTS AZNCF opened at $138.88 on Monday. The company has a 50-day simple moving average of $130.91 and a two-hundred day simple moving average of $130.68. AstraZeneca has a 12-month low of $118.16 and a 12-month high of $153.10.

AstraZeneca Increases Dividend

The business also recently announced a dividend, which was paid on Monday, March 25th. Investors of record on Friday, February 23rd were issued a dividend of $1.97 per share. The ex-dividend date was Wednesday, February 21st. This is a boost from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio is currently 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.